The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic stem cell transplantation (HSCT) for individuals with myelodysplastic syndromes (MDS) based on requests from ASH, ASTCT, NMDP, and CIBMTR.
Read Press ReleaseThe controversial devices are linked to at least 27 deaths and over 300 additional injuries. Many devices can become difficult or impossible to retrieve if left in for more than 30-45 days after implant.
Read Press ReleaseJournal of Thrombosis and Haemostasis publishes article on first internationally developed and reviewed Core Curriculum to guide clinical knowledge and training in the industry
Read Press Release